Get started
BioVaxys Technology Corp.BioVaxys Technology Corp.BioVaxys Technology Corp.

BioVaxys Technology Corp.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BVAXF chart


Full chart

Key stats


Market capitalization
‪11.91 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.0215 USD
Net income (FY)
‪−5.54 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪221.58 M‬
Beta (1Y)
−0.37

About BIOVAXYS TECHNOLOGY CORP.


Sector
Non-Energy Minerals
Industry
Other Metals/Minerals
CEO
James Christopher Passin
Website
biovaxys.com
Headquarters
Etobicoke
Founded
2018
FIGI
BBG00MTP1TR0
BioVaxys Technology Corp. is a clinical stage biotechnology company. It engages in developing viral and oncology vaccine platforms, as well as immuno-diagnostics. The firm is advancing a SARS-CoV-2 vaccine based on its haptenized viral protein technology and is preparing for a clinical trial of its haptenized autologous cell vaccine used in combination with anti-PD1 and anti-PDL-1 checkpoint inhibitors that will initially be developed for Stage III/Stage IV ovarian cancer. The company was founded by James Christopher Passin, Kenneth E. Kovan and David Berd on April 25, 2018 and is headquartered in Etobicoke, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BVAXF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BVAXF is 0.0498 USD — it has decreased by −1.39% in the past 24 hours. Watch BioVaxys Technology Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange BioVaxys Technology Corp. stocks are traded under the ticker BVAXF.
BVAXF stock has risen by 1.01% compared to the previous week, the month change is a 12.75% rise, over the last year BioVaxys Technology Corp. has showed a 24.81% increase.
BVAXF reached its all-time high on Feb 16, 2021 with the price of 0.6200 USD, and its all-time low was 0.0013 USD and was reached on Feb 12, 2019. View more price dynamics on BVAXF chart.
See other stocks reaching their highest and lowest prices.
BVAXF stock is 10.26% volatile and has beta coefficient of −0.37. Track BioVaxys Technology Corp. stock price on the chart and check out the list of the most volatile stocks — is BioVaxys Technology Corp. there?
Today BioVaxys Technology Corp. has the market capitalization of ‪11.91 M‬, it has increased by 0.82% over the last week.
Yes, you can track BioVaxys Technology Corp. financials in yearly and quarterly reports right on TradingView.
BVAXF net income for the last quarter is ‪−859.21 K‬ USD, while the quarter before that showed ‪−393.67 K‬ USD of net income which accounts for −118.25% change. Track more BioVaxys Technology Corp. financial stats to get the full picture.
No, BVAXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BVAXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioVaxys Technology Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioVaxys Technology Corp. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioVaxys Technology Corp. stock shows the neutral signal. See more of BioVaxys Technology Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.